165 related articles for article (PubMed ID: 35067539)
21. Diagnostic value of integrated
Yu Y; Zhang L; Sultana B; Wang B; Sun H
BMC Cancer; 2022 Sep; 22(1):947. PubMed ID: 36050751
[TBL] [Abstract][Full Text] [Related]
22. Assessment of multifocality and axillary nodal involvement in early-stage breast cancer patients using 18F-FDG PET/CT compared to contrast-enhanced and diffusion-weighted magnetic resonance imaging and sentinel node biopsy.
Ergul N; Kadioglu H; Yildiz S; Yucel SB; Gucin Z; Erdogan EB; Aydin M; Muslumanoglu M
Acta Radiol; 2015 Aug; 56(8):917-23. PubMed ID: 25013091
[TBL] [Abstract][Full Text] [Related]
23. A prospective comparative study of ultrasonography, contrast-enhanced MRI and 18F-FDG PET/CT for preoperative detection of axillary lymph node metastasis in breast cancer patients.
Guney IB; Dalci K; Teke ZT; Kucuker KA
Ann Ital Chir; 2020; 91():458-464. PubMed ID: 32213685
[TBL] [Abstract][Full Text] [Related]
24. A prospective comparative study of contrast-enhanced CT, contrast-enhanced MRI and 18F-FDG PET/CT in the preoperative staging of colorectal cancer patients.
Guney IB; Teke Z; Kucuker KA; Yalav O
Ann Ital Chir; 2020; 91():658-667. PubMed ID: 32213686
[TBL] [Abstract][Full Text] [Related]
25. Is FDG-PET/CT used correctly in the combined approach for nodal staging in NSCLC patients?
Simsek FS; Comak A; Asik M; Kuslu D; Balci TA; Ulutas H; Koroglu R; Kekilli E; Akatli A; Elmali F; Yalcin NC; Akyol H
Niger J Clin Pract; 2020 Jun; 23(6):842-847. PubMed ID: 32525121
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic performance of 18F-FDG PET/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients.
An YS; Lee DH; Yoon JK; Lee SJ; Kim TH; Kang DK; Kim KS; Jung YS; Yim H
Nuklearmedizin; 2014; 53(3):89-94. PubMed ID: 24220324
[TBL] [Abstract][Full Text] [Related]
27. Exploratory radiomic features from integrated
Baiocco S; Sah BR; Mallia A; Kelly-Morland C; Neji R; Stirling JJ; Jeljeli S; Bevilacqua A; Cook GJR; Goh V
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1478-1484. PubMed ID: 30919055
[TBL] [Abstract][Full Text] [Related]
28. Value of metabolic parameters of primary lesions examined by 18F-FDG PET/CT for endometrial cancer in preoperative evaluation.
Gai QZ; Lv YB; Li GY; Zhang DQ; Gao Z; Fang XH
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2493-2502. PubMed ID: 33829435
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic accuracy of dual-time-point 18F-FDG PET/CT for the detection of axillary lymph node metastases in breast cancer patients.
Hahn S; Hecktor J; Grabellus F; Hartung V; Pöppel T; Kimmig R; Forsting M; Antoch G; Heusner TA
Acta Radiol; 2012 Jun; 53(5):518-23. PubMed ID: 22547387
[TBL] [Abstract][Full Text] [Related]
30. Feasibility and utility of MRI and dynamic
Espedal H; Berg HF; Fonnes T; Fasmer KE; Krakstad C; Haldorsen IS
J Transl Med; 2021 Sep; 19(1):406. PubMed ID: 34565386
[TBL] [Abstract][Full Text] [Related]
31. Value of magnetic resonance and ¹⁸FDG PET-CT in predicting tumor response and resectability of primary locally advanced cervical cancer after treatment with intensity-modulated arc therapy: a prospective pathology-matched study.
Vandecasteele K; Delrue L; Lambert B; Makar A; Lambein K; Denys H; Tummers P; Van den Broecke R; Villeirs G; De Meerleer G
Int J Gynecol Cancer; 2012 May; 22(4):630-7. PubMed ID: 22237382
[TBL] [Abstract][Full Text] [Related]
32. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
Jensen TK; Holt P; Gerke O; Riehmann M; Svolgaard B; Marcussen N; Bouchelouche K
Scand J Urol Nephrol; 2011 Mar; 45(2):122-8. PubMed ID: 21231796
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Value of 16α-
Yamada S; Tsuyoshi H; Yamamoto M; Tsujikawa T; Kiyono Y; Okazawa H; Yoshida Y
J Nucl Med; 2021 May; 62(5):636-642. PubMed ID: 33008930
[TBL] [Abstract][Full Text] [Related]
34. Correlation of Minimum Apparent Diffusion Coefficient and Maximum Standardized Uptake Value of the Primary Tumor with Clinicopathologic Characteristics in Endometrial Cancer.
Sürer Budak E; Toptaş T; Aydın F; Öner AO; Çevikol C; Şimşek T
Mol Imaging Radionucl Ther; 2017 Feb; 26(1):24-32. PubMed ID: 28291007
[TBL] [Abstract][Full Text] [Related]
35. Preoperative risk stratification using metabolic parameters of (18)F-FDG PET/CT in patients with endometrial cancer.
Kitajima K; Suenaga Y; Ueno Y; Maeda T; Ebina Y; Yamada H; Okunaga T; Kubo K; Sofue K; Kanda T; Tamaki Y; Sugimura K
Eur J Nucl Med Mol Imaging; 2015 Jul; 42(8):1268-75. PubMed ID: 25833351
[TBL] [Abstract][Full Text] [Related]
36. Prospective evaluation of whole-body MRI and
Bruckmann NM; Sawicki LM; Kirchner J; Martin O; Umutlu L; Herrmann K; Fendler W; Bittner AK; Hoffmann O; Mohrmann S; Dietzel F; Ingenwerth M; Schaarschmidt BM; Li Y; Kowall B; Stang A; Antoch G; Buchbender C
Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2816-2825. PubMed ID: 32333068
[TBL] [Abstract][Full Text] [Related]
37. Pilot Study of [
Eulitt PJ; Altun E; Sheikh A; Wong TZ; Woods ME; Rose TL; Wallen EM; Pruthi RS; Smith AB; Nielsen ME; Whang YE; Kim WY; Godley PA; Basch EM; David GU; Ramirez J; Deal AM; Rathmell WK; Chen RC; Bjurlin MA; Lin W; Lee JK; Milowsky MI
Clin Genitourin Cancer; 2020 Oct; 18(5):378-386.e1. PubMed ID: 32147364
[TBL] [Abstract][Full Text] [Related]
38. Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging--initial findings.
Stadnik TW; Everaert H; Makkat S; Sacré R; Lamote J; Bourgain C
Eur Radiol; 2006 Oct; 16(10):2153-60. PubMed ID: 16670863
[TBL] [Abstract][Full Text] [Related]
39. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic performance of preoperative [
Rufini V; Garganese G; Ieria FP; Pasciuto T; Fragomeni SM; Gui B; Florit A; Inzani F; Zannoni GF; Scambia G; Giordano A; Collarino A
Eur J Nucl Med Mol Imaging; 2021 Sep; 48(10):3303-3314. PubMed ID: 33619601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
